Related Experiment Video
Updated: Aug 12, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
HIV infection in haemophilia--a European cohort
A Aronstam1, B Congard, D I Evans
1Basingstoke District Hospital, UK.
Insights
HIV infection in children with hemophilia is serious. Shingles indicates worse outcomes, while rising IgA levels signal disease progression. Modern treatments delay AIDS but do not stop CD4 cell decline.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Immunology
Background:
- HIV infection in children with hemophilia poses significant health challenges.
- Early HIV infection in this cohort occurred between 1979 and 1986.
- Data was collected from ten Northern European hemophilia centers.
Purpose of the Study:
- To analyze the progression of HIV infection in hemophilic children.
- To identify clinical indicators of disease progression.
- To evaluate the impact of evolving treatment strategies.
Main Methods:
- Retrospective analysis of pooled data from 202 hemophilic children infected with HIV.
- Monitoring of AIDS progression, mortality, and clinical symptoms like persistent generalized lymphadenopathy and shingles.
- Analysis of CD4+ T cell counts and IgA concentrations.
- Review of treatment patterns, including zidovudine use and prophylaxis.
Main Results:
- 18% of cases progressed to AIDS by 1991, with 15 deaths.
- Persistent generalized lymphadenopathy did not worsen prognosis; shingles was associated with poorer outcomes (53% had low CD4 counts).
- Rising IgA concentrations correlated with decreased CD4+ T cell counts, indicating disease progression.
- Increased use of zidovudine and prophylaxis reduced Pneumocystis pneumonia incidence from 56% to 20% between 1989 and 1991.
Conclusions:
- Shingles is a negative prognostic indicator in HIV-infected hemophilic children.
- Elevated IgA levels serve as a marker for HIV disease advancement.
- Current prophylactic treatments effectively delay AIDS-defining illnesses, although CD4+ T cell counts continue to decline.
Abstract:
Ten haemophilia centres in northern Europe have pooled data on 202 haemophilic children who were infected with HIV between 1979 and 1986. All cases were under 16 years of age on 1 July 1985. The age at infection ranged from 1-15 years. Thirty seven cases (18%) had progressed to AIDS by 1 July 1991 and 15 of these have died. Persistent generalised lymphadenopathy has been noted in 102 patients of whom 18 (17%) have developed AIDS. Twenty three of the remaining patients (23%) have not. CD4+ T cell counts have fallen steadily. Of 36 patients who have had shingles since seroconversion, 19 (53%) had counts below 0.2 x 10(9)/l. Thirty five out of 145 patients without shingles (24%) had similar values. The mean IgA concentration in patients with CD4+ T cell counts above 0.5 x 10(9)/l was 2.38 g/l, between 0.2 and 0.5 was 3.07 g/l, and in those with CD4+ T cell counts below 0.2 x 10(9)/l the mean IgA concentration was 4.58 g/l. Treatment patterns have altered between 1989 and 1991, with increased use of zidovudine in patients without AIDS and a marked increase in primary prophylaxis against pneumocystis pneumonia. This has been associated with a decline in the incidence of pneumocystis as an indicator disease in new AIDS cases from 56% in 1989 to 20% in 1991. These observations indicate that persistent generalised lymphadenopathy does not worsen the outlook, but shingles does. Rising IgA concentrations are markers for disease progression. Modern prophylactic regimens are delaying the onset of indicator disease, but CD4 values continue to fall steadily.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Viral Hepatitis I: Introduction

